1st Day Opening Plenary | Emerging Biotechnologies and their Potential to Cure and Transform Healthcare
We are at an inflection point in healthcare history. Through the power of genomics, diagnostics and biotechnology tools, healthcare of the future will be increasingly proactive, preventative, predictive, and personalized. This panel will explore the potential of biotech tools such as gene and cell therapies and genome editing and how innovation in this space can help support public health outcomes in Latin America.
- Alan Eisenberg, Vice President, Global Government Relations and Public Policy, Alnylam Pharmaceuticals
- João Sanches, Government Affairs & Corporate Communications Head, Novartis
- Katherine Tsokas, Global Regulatory Affairs, Head of Regenerative Medicine & Advanced Therapy, Janssen Research & Development
- Paulo Alvim, Secretary of Entrepreneurship and Innovation, Ministry of Science, Technology, Innovations and Communications